754 related articles for article (PubMed ID: 17379439)
1. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
2. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
[TBL] [Abstract][Full Text] [Related]
3. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer.
Iwata H; Murakami M; Demizu Y; Miyawaki D; Terashima K; Niwa Y; Mima M; Akagi T; Hishikawa Y; Shibamoto Y
Cancer; 2010 May; 116(10):2476-85. PubMed ID: 20225229
[TBL] [Abstract][Full Text] [Related]
4. High-dose proton beam therapy for Stage I non-small-cell lung cancer.
Nihei K; Ogino T; Ishikura S; Nishimura H
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):107-11. PubMed ID: 16458447
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy alone in elderly with early stage non-small cell lung cancer.
San José S; Arnaiz MD; Lucas A; Navarro V; Serrano G; Zaderazjko M; Jeremic B; Guedea F
Lung Cancer; 2006 May; 52(2):149-54. PubMed ID: 16516336
[TBL] [Abstract][Full Text] [Related]
7. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
8. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
[TBL] [Abstract][Full Text] [Related]
10. Proton beam therapy for aged patients with hepatocellular carcinoma.
Hata M; Tokuuye K; Sugahara S; Tohno E; Nakayama H; Fukumitsu N; Mizumoto M; Abei M; Shoda J; Minami M; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):805-12. PubMed ID: 17524568
[TBL] [Abstract][Full Text] [Related]
11. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba.
Nakayama H; Sugahara S; Tokita M; Satoh H; Tsuboi K; Ishikawa S; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):467-71. PubMed ID: 20056349
[TBL] [Abstract][Full Text] [Related]
13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
15. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.
Yu HM; Liu YF; Yu JM; Liu J; Zhao Y; Hou M
Radiother Oncol; 2008 Apr; 87(1):29-34. PubMed ID: 18237795
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
[TBL] [Abstract][Full Text] [Related]
17. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
[TBL] [Abstract][Full Text] [Related]
20. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
